Publication date: Jul 27, 2024
Aptamers are not so new a concept, however, it is scarcely discussed by medical fraternity. Aptamers are potent, new identification molecules set to rope in a new technique in the diagnostic arena. Aptamers have started almost a revolution in diagnostic assays since their discovery in the 90s. (Radu S. Current and previous disease outbreaks around the world, U. S. News & World Report. 2020 Mar 13 [cited 2024 Jun 17]. Available from: https://www. usnews. com/news/best-countries/slideshows/20-pandemic-and-epidemic-diseases-according-to-who) provides an overview of pandemics and epidemics as reported by the WHO. It is interesting to note that several endemic and epidemic diseases viz. Chikungunya, Cholera, Crimean-Congo haemorrhagic fever, Ebola virus disease, Hendra virus infection, Influenza, Lassa fever, Marburg virus disease, Meningitis, MERS-CoV (Middle East Respiratory Syndrome Corona Virus), Monkeypox, Nipah virus infection, Novel coronavirus, Plague, Rift Valley fever, SARS (Severe Acute Respiratory Syndrome), Smallpox, Tularaemia, Yellow fever, and Zika virus disease have been identified by the WHO and are being explored for applicability of aptamer technology in their identification. One of the most important necessities to control epidemic or pandemic diseases is early diagnosis. However, the majority of the diagnostic tests for these diseases are available only in tertiary care centres. The objective of this review is to discuss the potential of aptamer technology to provide undemanding, simple, specific, sensitive, and cost-effective diagnostic assays that are usable in remote and field conditions. Here, we discuss recent advances and approaches in aptamer and aptamer engineering useful in the diagnosis of infectious and non-infectious conditions. This review also discusses a few sensing discoveries which are a gift of advanced engineering and technology using optical and electrochemical aptasensors. It’s still a long way to go, and we need to take into account the technological challenges being faced by aptamer-aptasensor technology.
| Concepts | Keywords |
|---|---|
| Arena | aptamer |
| Coronavirus | aptasensor |
| Meningitis | SELEX |
| Monkeypox | surface-enhanced Raman spectroscopy |
| Simple |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Infectious Diseases |
| disease | VO | report |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | Cholera |
| disease | MESH | Crimean-Congo haemorrhagic fever |
| disease | MESH | Ebola virus disease |
| disease | MESH | Hendra virus infection |
| disease | MESH | Influenza |
| disease | MESH | Lassa fever |
| disease | MESH | Marburg virus disease |
| disease | MESH | Meningitis |
| disease | MESH | Middle East Respiratory Syndrome |
| disease | MESH | Monkeypox |
| disease | MESH | Plague |
| disease | MESH | Rift Valley fever |
| disease | MESH | Severe Acute Respiratory Syndrome |
| disease | MESH | Smallpox |
| disease | MESH | Yellow fever |
| disease | MESH | Zika virus disease |
| disease | VO | effective |